March 23, 2020
The UK has formed a genome sequencing alliance, to enable rapid, broad, large-scale sequencing analysis of samples from patients testing positive for COVID-19. The resulting data will help deliver insights into how the virus is transmitted and how it evolves. Oxford Nanopore is delighted to support participating teams across the UK in this project, including [...]
GigaMune Publishes Results in Nature Biotechnology Describing T Cell Receptor Discovery Technology
March 23, 2020
New technology screens hundreds-fold more T cell receptors (TCRs) than prior technologies to reveal rare TCRs with therapeutic potential SOUTH SAN FRANCISCO, Calif. -- GigaMune, a cancer cell therapy company focused on T cell receptor (TCR) discovery and development, today announced the publication of results describing its patented T cell receptor discovery technology in the prestigious [...]
Thermo Fisher Scientific Continues Investments to Accelerate Biopharma Commercialization
March 23, 2020
Capabilities and capacity now available to help customers of all sizes meet increasing demand for new biologics, cell and gene therapies, and drug products NEEDHAM, Mass. -- For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug products, Thermo Fisher Scientific is investing more than $475 million in new capabilities and [...]
Avantor Appoints Tommy Thomas as Vice President, Investor Relations
March 23, 2020
ADNOR, Pa., -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced Tommy Thomas has joined the Company as Vice President, Investor Relations. He will report to Thomas Szlosek, Executive Vice President and Chief Financial Officer, and [...]
March 23, 2020
NEW YORK-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced an expanded collaboration with AstraZeneca focused on refining a biologics modeling solution with the aim of speeding up the development of antibody and protein-based therapeutic candidates. The multi-year agreement extends an existing collaboration in [...]
Nomination Committee proposes Torben Jørgensen for new chairman of Genovis
March 23, 2020
Genovis’ Nomination Committee proposes new election of Torben Jørgensen to serve on the Board of Directors and as Chairman of the Board at the Annual General Meeting on May 5. Torben Jørgensen was born in 1952 and is currently Chairman of the Board of Biotage AB and Atlas Antibodies AB. He also serves on the [...]
FluroTech Announces New US Distributor
March 23, 2020
Calgary, Alberta – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical Cannabis and Hemp testing market, is pleased to announce it has entered into an non-exclusive US distribution agreement with North Carolina based HempLab Inc. The distribution agreement provides for FluroTech and HempLab to work together [...]
March 23, 2020
The universal digital platform from Metrohm integrates the latest laboratory balance from Sartorius Thanks to an extension (QApp) implemented on the balance, Cubis® II from Sartorius has become a fully integrated module of the OMNIS platform. Opening OMNIS to leading third-party manufacturers underlines the commitment of the global market leader in titration to create the preferred [...]
CloudLIMS Offers Free LIMS Globally to SARS-CoV-2 & COVID-19 Research & Testing Laboratories
March 21, 2020
Wilmington, Delaware – CloudLIMS recognizes the threat to global health the COVID-19 pandemic brings. To do our part, we are making our flagship in the cloud LIMS (Laboratory Information Management System), CloudLIMS Enterprise, free of charge to any research facility or diagnostics laboratory doing SARS-CoV-2 or COVID-19 research or testing, be it any part of [...]
March 20, 2020
BOSTON, Mass. — GE (NYSE:GE) announced that, together with Danaher Corporation (NYSE:DHR) (“Danaher”), it has entered into a consent decree agreement with the U.S. Federal Trade Commission (the “FTC”) in connection with GE’s definitive agreement to sell its BioPharma business to Danaher for approximately $20 billion of net proceeds. GE currently expects to close the [...]
